J O Contreres
Overview
Explore the profile of J O Contreres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Contreres J, Faure R, Baquiran G, Bergeron J, Posner B
J Biol Chem
. 1998 Aug;
273(34):22007-13.
PMID: 9705342
Incubating endosomes with ATP decreased binding of 125I-insulin but not 125I-labeled human growth hormone. Increasing ATP concentrations from 0.1 to 1 mM increased beta-subunit tyrosine phosphorylation and insulin receptor kinase...
2.
Band C, Posner B, Dumas V, Contreres J
Mol Endocrinol
. 1998 Feb;
11(13):1899-910.
PMID: 9415395
Peroxovanadiums (pVs) are potent protein tyrosine phosphatase (PTP) inhibitors with insulin-mimetic properties in vivo and in vitro. We have established the existence of an insulin receptor kinase (IRK)-associated PTP whose...
3.
Ponzio G, Contreres J, Debant A, Auberger P, Farahifar D, Rossi B
Growth Factors
. 1990 Jan;
4(1):37-44.
PMID: 1982214
We provide evidence that both covalent and non-covalent inhibitors of chymotrypsin-like activities inhibit the insulin-induced DNA replication, while the hormonal metabolic effects such as induction of tyrosine aminotransferase activity or...
4.
Cell-cycle regulation of insulin-stimulated tyrosine aminotransferase activity in rat hepatoma cells
Contreres J, Debant A, Ponzio G, Rossi B
Cell Signal
. 1990 Jan;
2(5):439-50.
PMID: 1980597
Amongst the proteins that are subjected to variation during the cell division cycle few are under hormonal regulation. The variation in amount of tyrosine aminotransferase (TAT) in the hepatic tissue...
5.
Ponzio G, Debant A, Contreres J, Rossi B
Cell Signal
. 1990 Jan;
2(4):377-86.
PMID: 1979229
Expression of insulin metabolic effects can be obtained by anti-receptor antibodies without activation of the tyrosine kinase activity [O'Brien R. M., Soos M. A. and Siddle K. (1987) EMBO J....
6.
Auberger P, Falquerho L, Contreres J, Pages G, Le Cam G, Rossi B, et al.
Cell
. 1989 Aug;
58(4):631-40.
PMID: 2766355
Amino acid sequence of the precursor of the phosphorylated N-glycoprotein (pp63) secreted by rat hepatocytes was deduced from the cDNA sequence. This polypeptide (Mr = 40,586) was rich in both...
7.
Debant A, Ponzio G, Clauser E, Contreres J, Rossi B
Biochemistry
. 1989 Jan;
28(1):14-7.
PMID: 2650737
The pivotal role that the tyrosine residues in positions 1162 and 1163 play in the control of the insulin action has been clearly established by substitution of these tyrosine residues...
8.
Ponzio G, Contreres J, Debant A, Baron V, Gautier N, Rossi B
EMBO J
. 1988 Dec;
7(13):4111-7.
PMID: 3072194
In a previous report we described the properties of a rabbit anti-insulin receptor antibody (RAIR-IgG) and its effects on the autophosphorylation and kinase activity of human insulin receptors. The present...
9.
Debant A, Clauser E, Ponzio G, Filloux C, Auzan C, Contreres J, et al.
Proc Natl Acad Sci U S A
. 1988 Nov;
85(21):8032-6.
PMID: 3186705
Chinese hamster ovary transfectants that express insulin receptors in which tyrosine residues 1162 and 1163 were replaced by phenylalanine exhibit a total inhibition of the insulin-mediated tyrosine kinase activity toward...